- Home
- WEA vs INO Comparison
WEA vs INO Comparison
Compare WEA & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WEA | INO |
|---|---|---|
| Founded | 2002 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 131.1M | 136.6M |
| IPO Year | N/A | 1998 |
Fundamental Metrics
Financial Performance| Metric | WEA | INO |
|---|---|---|
| Price | $11.15 | $1.92 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 46.1K | ★ 1.3M |
| Earning Date | 01-01-0001 | 11-10-2025 |
| Dividend Yield | ★ 7.87% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $182,337.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $14,751.49 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.60 | $1.30 |
| 52 Week High | $11.29 | $4.61 |
Technical Indicators
Market Signals| Indicator | WEA | INO |
|---|---|---|
| Relative Strength Index (RSI) | 53.74 | 43.48 |
| Support Level | $10.91 | $1.76 |
| Resistance Level | $11.12 | $2.10 |
| Average True Range (ATR) | 0.14 | 0.12 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 77.42 | 51.28 |
Price Performance
Historical ComparisonAbout WEA Western Asset Bond Fund Share of Beneficial Interest
Western Asset Premier Bond Fund is a diversified closed-end management investment company. Its investment objective is to provide current income and capital appreciation by investing in a diversified portfolio of investment-grade bonds. The Fund invests in sectors, such as financials, energy, telecommunication services, consumer discretionary, healthcare, materials, information technology, and consumer staples.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.